Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors Cover

.blurhash-client-img { display: none !important; }

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors

Acta Pharmaceutica

Volume 73 (2023): Issue 4 (December 2023)

By: Matea Baković, Martina Bago , Lucija Benić, Magdalena Krajinović, Tajana Silovski , Natalija Dedić Plavetić , Lu Turković , Miranda Sertić and Maja Ortner Hadžiabdić

Open Access

|Dec 2023

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/acph-2023-0045 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 633 - 654

Accepted on: Nov 30, 2023

Published on: Dec 26, 2023

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

advanced breast cancer,

oral anticancer therapy,

CDK 4/6 inhibitors,

depressive symptoms,

beliefs about medicines

Related subjects:

Pharmacy, other

© 2023 Matea Baković, Martina Bago, Lucija Benić, Magdalena Krajinović, Tajana Silovski, Natalija Dedić Plavetić, Lu Turković, Miranda Sertić, Maja Ortner Hadžiabdić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 73 (2023): Issue 4 (December 2023)Next article